Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
10.98
+0.19 (1.76%)
Jan 12, 2026, 4:00 PM EST - Market closed
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $214.66 million as of January 13, 2026.
Market Cap
214.66M
Enterprise Value
217.37M
1-Year Change
n/a
Ranking
Category
Stock Price
$10.98
Market Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has decreased from $308.79M to $214.66M, a decrease of -30.48%. That is a compound annual growth rate of -46.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 214.66M | -7.42% |
| Dec 31, 2025 | 231.86M | -24.91% |
| Jun 16, 2025 | 308.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |